Paid Clinical Trials in Ocala, FL
As of September 2026, 82 paid clinical trials are recruiting in Ocala, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Ocala offers studies at sites including Renstar Medical Research for conditions such as Obesity, Overweight, Carcinoma, Non-Small-Cell Lung, Chronic Pain. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Ocala
Trials by drug in Ocala
Filter results
Newly added in Ocala
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
76 clinical trials
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study of Buntanetap in Participants With PD
Study of DONQ52 in Active Celiac Disease
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Patient Retrospective Outcomes (PRO)
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Top Research Study Locations in Ocala
Researchers run research studies in Ocala, FL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Renstar Medical Research | Overweight, Alzheimer's Disease, Alzheimers Disease | 20 |
| Ocala Cardiovascular Research | Heart Failure, Obesity, Atherosclerotic Cardiovascular Disease (ASCVD) | 7 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease, Irritable Bowel Syndrome, Metabolic Dysfunction-associated Steatohepatitis | 5 |
| Ocala Oncology Center | Colorectal Cancer, Melanoma, Multiple Myeloma (MM) | 4 |
| Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala | Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis | 3 |
| Ocala Research Institute, Inc | Cardiovascular Disease, Early Breast Cancer, Heart Failure | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| Inmagene | Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema | 2 |
| Ocala GI Research | Celiac Disease, Metabolic Dysfunction-associated Steatohepatitis | 2 |
| Ocala Oncology | Advanced Solid Tumor, Breast Neoplasms, Carcinoma, Ductal, Breast | 2 |
| ACCOMPLISH-1 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Advanced Surgl Care of Ocala | Lumbar Spinal Stenosis | 1 |
| Advanced Urology Institute | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 1 |
| Altimmune Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Central Florida Endoscopy and Surgical Institute of Ocala | Lumbar Spinal Stenosis | 1 |
| Florida Cancer Affiliates - Ocala | Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Phase | 1 |
| Florida Cancer Affiliates - Ocala Oncology | Metastatic Non-small Cell Lung Cancer | 1 |
| Florida Cancer Specialists | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 1 |
| Florida Pain Clinic | Chronic Pain | 1 |
| HCA Florida Ocala Hospital | Aortic Valve Disease, Aortic Valve Stenosis, Heart Disease Structural Disorder | 1 |
Active & Upcoming Studies in Ocala (2026)
Recruiting trials in Ocala grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (20 active studies)
- A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma · Phase 1 · Shanghai Henlius Biotech
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · Natera, Inc.
Diabetes & metabolic (15 active studies)
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity · Phase 3 · Eli Lilly and Company
- AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications · Phase 3 · Novo Nordisk A/S
Neurology & pain (7 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain · Phase 2 · Eli Lilly and Company
Cardiovascular (7 active studies)
Mental health & behavior (1 active study)
- Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athletes With Co-morbid Depression and Concussion · Phase 2, Phase 3 · University of Florida
Common conditions studied in Ocala
- Obesity (6 active studies)
- Overweight (5 active studies)
- Carcinoma, Non-Small-Cell Lung (4 active studies)
- Chronic Pain (3 active studies)
- Heart Failure (3 active studies)
- Non-Small Cell Lung Cancer (3 active studies)
Leading research sponsors in Ocala
- Eli Lilly and Company
- AstraZeneca
- Bristol-Myers Squibb
- GlaxoSmithKline
- Amgen
Frequently asked questions
How many paid clinical trials are currently recruiting in Ocala?
There are approximately 82 recruiting clinical trials in Ocala, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Ocala pay participants?
Most recruiting trials in Ocala compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Ocala?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Ocala?
The most common conditions under active study in Ocala include Obesity (6), Overweight (5), Carcinoma, Non-Small-Cell Lung (4), Chronic Pain (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Ocala?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Ocala on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Ocala?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Ocala?
Recruiting research sites in Ocala include Renstar Medical Research, Ocala Cardiovascular Research, GSK Investigational Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Ocala right now?
The largest active categories in Ocala are Cancer & tumors (20), Diabetes & metabolic (15), Neurology & pain (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.